The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers, 2002Ultra High Field MRS Assessment of MPTP, Rotenone, & BSO Effects in Rodents
Recent technical developments with magnetic resonance spectroscopy (MRS) have provided an extraordinary ability to non-invasively monitor brain function in humans. The neurochemical biopsy afforded...
-
Biomarkers, 2002Non-Invasive Markers of Oxidatvie Stress in Human Brain
Many current theories on the development of Parkinson's disease include the notion that changes in the biochemistry of the brain usually precede any structural changes, which can be picked up by MRI...
-
Biomarkers, 2002Peripheral Benzodiazepine Receptor: An In Vivo Biomarker of Parkinson's Disease
The goal of the proposed studies is to validate an early marker of Parkinson's disease (PD) that may be able to identify disease onset prior to clinical manifestation. It is now recognized that in PD...
-
Biomarkers, 2002Simple Blood Tests for Parkinson's Disease Derived from Genome-wide Expression Changes
The diagnosis of Parkinson's disease relies on expert opinion. Autopsy studies, however, have demonstrated that even experienced neurologists misdiagnose Parkinson's disease in about a quarter out of...
-
Biomarkers, 2002State & Trait Markers for Parkinson's Disease in CSF, Plasma, & Urine from Datatop
Although the clinical features of Parkinson's disease (PD) and its changes in the brain are unmistakable, it lacks identified biochemical clues that could enhance early diagnosis of this disorder. We...
-
Biomarkers, 2002Characterization of Alpha Synuclein in Human Fluids & Brain as a Biomarker for Parkinson's Disease
To date there is no readily accessible laboratory test available for the diagnosis of Parkinson disease. The diagnosis of probable PD is generally made over time by a neurologist who serially examines...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.